Induction by mercury compounds of metallothioneins in mouse tissues: Inorganic mercury accumulation is not a dominant factor for metallothionein induction in the liver

Journal of Toxicological Sciences

Volumn 36, Issue 3, 2011, Pages 365-372

  Yasutake, Akira ^a   Nakamura, Masaaki ^a  

^a NATIONAL INSTITUTE FOR MINAMATA DISEASE   (Japan)

Author keywords

IL6; Inorganic mercury; Mercury vapor; Metallothionein; Methylmercury

Indexed keywords

INORGANIC COMPOUND; INTERLEUKIN 6; MERCURY; METALLOTHIONEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BIOACCUMULATION; BRAIN TISSUE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; KIDNEY PARENCHYMA; LETTER; LIVER; METAL METABOLISM; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION;

ANIMALIA;

EID: 79958050922     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.36.365     Document Type: Letter

References (17)

1. Aschner, M. (1989): Brain, kidney and liver 203Hg-methyl mercury uptake in the rat: relationship to the neutral amino acid carrier. Pharmacol. Toxicol., 65, 17-20.
2. Hirayama, K. (1985): Effects of combined administration of thiol compounds and methylmercury chloride on mercury distribution in rats. Biochem. Pharmacol., 34, 2030-2032.
3. Hirayama, K. and Yasutake, A. (1999): Effects of reactive oxygen modulators on in vivo demethylation of methylmercury. J. Health Sci., 45, 24-27.
4. Mori, N., Yasutake, A. and Hirayama, K. (2007): Comparative study of activities in reactive oxygen species production/defense system in mitochondria of rat brain and liver, and their susceptibility to methylmercury toxicity. Arch. Toxicol., 81, 769-776.
5. Mori, N., Yasutake, A., Marumoto, M. and Hirayama, K. (2011): Methylmercury inhibits electron transport chain activity and induces cytochrome c release in cerebellum mitochondria. J. Toxicol. Sci., 36, 253-259.
6. Naganuma, A., Satoh, M. and Imura, N. (1987): Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice. Cancer Res., 47, 983-987.
7. Nakamura, M., Yasutake, A., Fujimura, M., Hachiya, N. and Marumoto, M. (2011): Effect of methylmercury administrationon choroid plexus function in rats. Arch. Toxicol., in press.
8. Ohkawa, H., Ohishi, N. and Yagi, K. (1979): Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 95, 351-358.
9. Ohkawa, T., Uenoyama, H., Tanida, K. and Ohmae, T. (1977): Ultra trace mercury analysis by dry thermal decomposition in alumina porcelain tube. J. Hyg. Chem., 23, 13-22.
10. Raynes, J.G., Eagling, S. and McAdam, K.P. (1991): Acute-phase protein synthesis in human hepatoma cells: differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin-1 and interleukin-6. Clin. Exp. Immunol., 83, 488-491.
11. Tietze, F. (1969): Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem., 27, 502-522.
12. WHO (1991): IPCS Environmental Health Criteria 118 Inorganic Mercury. World Health Organization, Geneva.
13. Yasutake, A. and Hirayama, K. (1990): Selective quantification of inorganic mercury in tissues of methylmercury-treated rats. Bull. Environ. Contam. Toxicol., 45, 662-666.
14. Yasutake, A. and Hirayama, K. (1994): Acute effects of methylmercury on hepatic and renal glutathione metabolisms in mice. Arch. Toxicol., 68, 512-516.
15. Yasutake, A. and Hirayama, K. (2001): Evaluation of methylmercury biotransformation using rat liver slices. Arch. Toxicol., 75, 400-406.
16. Yasutake, A., Hirayama, K. and Inouye, M. (1990): Sex difference in acute renal dysfunction induced by methylmercury in mice. Ren. Fail., 12, 233-240.
17. Yasutake, A., Nakano, A. and Hirayama, K. (1998): Induction by mercury compounds of brain metallothionein in rats: Hg0 exposure induces long-lived brain metallothionein. Arch. Toxicol., 72, 187-191.